Yasunori Ueda

High Complete Remission Rate and Promising Outcome by Combination of Imatinib and Chemotherapy for Newly Diagnosed <i>BCR</i>-<i>ABL</i>–Positive Acute Lymphoblastic Leukemia: A Phase II Study by the Japan Adult Leukemia Study Group

Masamitsu Yanada, Jin Takeuchi, Isamu Sugiura et al. · Journal of Clinical Oncology · 2005 · 454 citations · Full text

Medicine, Hematology, Oncology +15

Clinical characteristics and outcome of human herpesvirus-6 encephalitis after allogeneic hematopoietic stem cell transplantation

Masao Ogata, Kiyohiro Oshima, Taichi Ikebe et al. · Bone Marrow Transplantation · 2017 · 119 citations · Full text

Medicine, Hematology, Infectious Diseases +13

Markedly improved outcomes and acceptable toxicity in adolescents and young adults with acute lymphoblastic leukemia following treatment with a pediatric protocol: a phase II study by the Japan Adult Leukemia Study Group

Fumihiko Hayakawa, Toru Sakura, Toshiaki Yujiri et al. · Blood Cancer Journal · 2014 · 105 citations · Full text

Medicine, Oncology, Pediatrics +14

Pre-transplant imatinib-based therapy improves the outcome of allogeneic hematopoietic stem cell transplantation for BCR–ABL-positive acute lymphoblastic leukemia

Shuichi Mizuta, Keitaro Matsuo, Fumiharu Yagasaki et al. · Leukemia · 2010 · 102 citations

Medicine, Hematology, Oncology +13

Prospective monitoring of <i>BCR‐ABL1</i> transcript levels in patients with Philadelphia chromosome‐positive acute lymphoblastic leukaemia undergoing imatinib‐combined chemotherapy

Masamitsu Yanada, Isamu Sugiura, Jin Takeuchi et al. · British Journal of Haematology · 2008 · 101 citations · Full text

Medicine, Hematology, Oncology +17